Skip to content

A research study of a new medicine, NNC9733-0001, in healthy participants and participants with type 2 diabetes

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-519382-22-00
Acronym
NN9733-8133
Enrollment
72
Registered
2025-10-24
Start date
2025-11-10
Completion date
Unknown
Last updated
2025-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Participants and Participants with type 2 diabetes

Interventions

None listed

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026